Inspire Pharmaceuticals, Inc. Release: Data Presentations at North American Cystic Fibrosis Conference Highlight Denufosol's Novel Mechanism of Action

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that data will be presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during oral and poster presentations at the 24th Annual North American Cystic Fibrosis Conference (NACFC) October 21-23, 2010 in Baltimore, Maryland.

Back to news